SCHEMBL6718939

SCHEMBL6718939

N#Cc1ccccc1-c1cccc2cc3n(c12)CCNCC3

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.52
HTR2C P28335 6/20 0.52
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PARP1 P09874 5/20 0.37
PLAT P00750 1/20 0.36
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
PNMT P11086 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714423 0.90 HTR2A (0.46) HTR2AHTR2CKDM4EMEN1LMNA
SCHEMBL6718606 0.83 HTR2A (0.49) HTR2AHTR2CPARP1DRD2DRD3
SCHEMBL6715788 0.82 HTR2A (0.43) HTR2AHTR2CKDM4EMEN1LMNA
SCHEMBL6711332 0.82 HTR2A (0.48) HTR2AHTR2CLMNACYP1A2CYP3A4
SCHEMBL6714489 0.81 HTR2A (0.45) HTR2AHTR2CPARP1DRD2DRD3
SCHEMBL6713804 0.81 HTR2A (0.56) HTR2AHTR2CMEN1CYP1A2CYP3A4
SCHEMBL6715280 0.81 HTR2A (0.56) HTR2AHTR2CKDM4ELMNACYP1A2
SCHEMBL6715392 0.81 HTR2A (0.59) HTR2AHTR2CMEN1CYP1A2CYP3A4
SCHEMBL6713706 0.81 HTR2A (0.58) HTR2AHTR2CPARP1
SCHEMBL6714459 0.79 HTR2A (0.43) HTR2AHTR2CCYP1A2PARP1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds ENNIS MICHAEL DALTON (US) 2004-10-21 US disclosed
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds PHARMACIA & UPJOHN COMPANY 2002-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HTR1D, HTR1A, HTR1E HTR2A 18/4885HTR2C 7/4885KDM4E 1296/4885
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HCRTR2, NR2C2, RCOR3 HTR2A 1403/4885HTR2C 553/4885KDM4E 3204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.